Cost Burden Analysis: To calculate the income burden faced in each state, we compared the average monthly out-of-pocket price of GLP-1 medications (pricing assumptions reflect a blended cash-pay range of approximately $150$450 per month, with $350 used as a common injectable reference point rather than a universal baseline) to each states per capita annual income
Areas of leakage, blockage, or abnormal new vessels light up clearly on these images
This clearly highlights the critical role of pharmacovigilance and ADR reporting in ensuring patient safety
Short-term NET spheroids were isolated from patient tumor samples and were grown in DMEM/F12 medium supplemented with 10% FBS, 1% PEN/STREP, 1% glutamine, 10 mM nicotinamide, and 10 g/mL insulin, as previously described (14, 15)
Patients often ask how long they will need to take tirzepatide